East China Engineering Science and Technology (002140.SZ) signed a strategic cooperation framework agreement with Qinghai Dongtai Jinai'er Lithium Resources Co., Ltd.
Donghua Technology (002140.SZ) announced that the company has recently signed a "Strategic Cooperation Framework Agreement" with Qinghai Dongtai Jinai Lithium Resources Co., Ltd. (referred to as "Lithium Resources"), agreeing to establish a strategic partnership and cooperate on the development and utilization of resources in the Dongtai Jinai Salt Lake.
East China Engineering Science and Technology (002140.SZ) announced that the company has signed a "Strategic Cooperation Framework Agreement" with Qinghai Dongtai Ji'nai'er Lithium Resources Co., Ltd. (referred to as "Lithium Resources") recently. The agreement stipulates that the two parties will establish a strategic partnership and cooperate on the development and utilization of the Dongtai Ji'nai'er salt lake new salt lake resource comprehensive development project.
The signing of the "Strategic Cooperation Framework Agreement" this time, to carry out cooperation on the development and utilization of the Dongtai Ji'nai'er salt lake new salt lake resource comprehensive development project, will further enhance the company's engineering performance and brand advantages in the market related to comprehensive development and utilization of salt lake resources.
Related Articles
.png)
CICC data: 190,500 new margin trading accounts opened in January, a year-on-year increase of 157.09%.

KNOWLEDGE ATLAS(02513): Exercise all excess rights issue rights, stabilize price actions, and end the stabilization period.

Botox's long-awaited growth drives the recovery of the medical beauty industry! AbbVie's Q4 financial report (ABBV.US) exceeds expectations, while simultaneously raising full-year profit guidance.
CICC data: 190,500 new margin trading accounts opened in January, a year-on-year increase of 157.09%.
.png)
KNOWLEDGE ATLAS(02513): Exercise all excess rights issue rights, stabilize price actions, and end the stabilization period.

Botox's long-awaited growth drives the recovery of the medical beauty industry! AbbVie's Q4 financial report (ABBV.US) exceeds expectations, while simultaneously raising full-year profit guidance.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


